by Stacey Johnson | Nov 29, 2024
Are you familiar with the Gartner Hype Cycle? It’s a way of separating reality from hype when it comes to emerging technologies – like cell and gene therapies (CGTs). The hype cycle employs a graph to present the maturity of new technologies as they pass through five...
by Lyla El-Fayomi | Sep 12, 2024
Welcome to a special edition of my blog that summarizes all the big news from the summer. I hope you’ve all been able to soak up (safely) as much sun as possible. Below, I cover the latest in aging, global trends in clinical trials for engineered biomaterials,...
by Stacey Johnson | Aug 30, 2024
This has never happened before. In eight years of hosting the blog carnival, we have never encountered a situation where the conclusions have been so similar. Given this year’s topic, the optimism is a good thing. So here is our topic: Venture financing in cell...
by Laya Kiani | Aug 15, 2024
According to the World Health Organization (WHO), in 2017, total global spending on health reached US$7.8 trillion and, by 2020, this figure had leapt to $9 trillion as governments raced to contain the first wave of COVID-19. The WHO estimates that worldwide spending...
Comments